The Asia Pacific Scar Treatment Market would witness market growth of 10.0% CAGR during the forecast period (2022-2028).
Deep FX is ideal for the removal of larger and deeper acne scars, whilst active FX is advised for the treatment of smaller and shallower scars caused by acne. The epidermis, the outermost and most delicate layer of the skin, is not harmed by this process; rather, only the dermis is affected by it. This is the primary benefit of this method.
The second benefit is that by the time you are through with the therapy, not only do you not have any scars, but your skin will also be younger, and it will be firmer. IPL, or intense pulsed light, is an effective treatment for brown or black acne scars. This therapy does not have much of an effect on the texture of the skin or acne, but it does act on the color of acne scars or skin that is prone to acne. It changes the color so that it matches the natural color of the skin again.
Additionally, it eliminates the germs that are the root cause of acne, which is a welcome bonus. The idea behind this therapy is that darker things absorb more light; thus, the laser light is made to be so powerful that even before it enters the normal skin, it is already absorbed in the region of skin which is darker owing to scars. This eliminates the need for further treatments. The pigmented cells are destroyed as a result of the heat that is absorbed.
The lack of road safety is a significant barrier to global development, a threat to public health, and the primary reason for both deaths and injuries on a global scale. According to the government of India, there have been a total of 4,12,432 registered road accidents in the nation during the year 2021. These incidents have resulted in the deaths of 1,53,972 people and the injuries of 3,84,448 other people. The rising incidence of traffic collisions has led to an increase in the number of persons who have been left with scars and markings from their stitches as a result of their injuries. As a result, the potential for expansion in the scar therapy market in the APAC region has increased.
The China market dominated the Asia Pacific Scar Treatment Market by Country in 2021; thereby, achieving a market value of $3,212.1 million by 2028. The Japan market is registering a CAGR of 9.3% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 10.6% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals, Clinics, and Retail Pharmacies/ E-commerce. Based on Product, the market is segmented into Topical Products (Creams, Gels, Silicon Sheets, and Others), Laser Products, Injectables, and Others. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Cynosure, LLC, Molnlycke Health Care AB (Investor AB), Suneva Medical, Inc., Perrigo Company PLC, Sientra, Inc., Bausch Health Companies, Inc. and Alma Lasers (Sisram Medical Ltd.)
Deep FX is ideal for the removal of larger and deeper acne scars, whilst active FX is advised for the treatment of smaller and shallower scars caused by acne. The epidermis, the outermost and most delicate layer of the skin, is not harmed by this process; rather, only the dermis is affected by it. This is the primary benefit of this method.
The second benefit is that by the time you are through with the therapy, not only do you not have any scars, but your skin will also be younger, and it will be firmer. IPL, or intense pulsed light, is an effective treatment for brown or black acne scars. This therapy does not have much of an effect on the texture of the skin or acne, but it does act on the color of acne scars or skin that is prone to acne. It changes the color so that it matches the natural color of the skin again.
Additionally, it eliminates the germs that are the root cause of acne, which is a welcome bonus. The idea behind this therapy is that darker things absorb more light; thus, the laser light is made to be so powerful that even before it enters the normal skin, it is already absorbed in the region of skin which is darker owing to scars. This eliminates the need for further treatments. The pigmented cells are destroyed as a result of the heat that is absorbed.
The lack of road safety is a significant barrier to global development, a threat to public health, and the primary reason for both deaths and injuries on a global scale. According to the government of India, there have been a total of 4,12,432 registered road accidents in the nation during the year 2021. These incidents have resulted in the deaths of 1,53,972 people and the injuries of 3,84,448 other people. The rising incidence of traffic collisions has led to an increase in the number of persons who have been left with scars and markings from their stitches as a result of their injuries. As a result, the potential for expansion in the scar therapy market in the APAC region has increased.
The China market dominated the Asia Pacific Scar Treatment Market by Country in 2021; thereby, achieving a market value of $3,212.1 million by 2028. The Japan market is registering a CAGR of 9.3% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 10.6% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals, Clinics, and Retail Pharmacies/ E-commerce. Based on Product, the market is segmented into Topical Products (Creams, Gels, Silicon Sheets, and Others), Laser Products, Injectables, and Others. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Cynosure, LLC, Molnlycke Health Care AB (Investor AB), Suneva Medical, Inc., Perrigo Company PLC, Sientra, Inc., Bausch Health Companies, Inc. and Alma Lasers (Sisram Medical Ltd.)
Scope of the Study
Market Segments Covered in the Report:
By End-use
- Hospitals
- Clinics
- Retail Pharmacies/ E-commerce
By Product
- Topical Products
- Creams
- Gels
- Silicon Sheets
- Others
- Laser Products
- Injectables
- Others
By Scar Type
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Smith & Nephew PLC
- Lumenis Be Ltd
- Merz Pharma GmbH & Co. KGaA
- Cynosure, LLC
- Molnlycke Health Care AB (Investor AB)
- Suneva Medical, Inc
- Perrigo Company PLC
- Sientra, Inc
- Bausch Health Companies, Inc
- Alma Lasers (Sisram Medical Ltd.)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Scar Treatment Market, by End-use
1.4.2 Asia Pacific Scar Treatment Market, by Product
1.4.3 Asia Pacific Scar Treatment Market, by Scar Type
1.4.4 Asia Pacific Scar Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Scar Treatment Market
Chapter 4. Asia Pacific Scar Treatment Market by End-use
4.1 Asia Pacific Hospitals Market by Country
4.2 Asia Pacific Clinics Market by Country
4.3 Asia Pacific Retail Pharmacies/ E-commerce Market by Country
Chapter 5. Asia Pacific Scar Treatment Market by Product
5.1 Asia Pacific Topical Products Market by Country
5.2 Asia Pacific Scar Treatment Market by Topical Products Type
5.2.1 Asia Pacific Creams Market by Country
5.2.2 Asia Pacific Gels Market by Country
5.2.3 Asia Pacific Silicon Sheets Market by Country
5.2.4 Asia Pacific Others Market by Country
5.3 Asia Pacific Laser Products Market by Country
5.4 Asia Pacific Injectables Market by Country
5.5 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Scar Treatment Market by Scar Type
6.1 Asia Pacific Atrophic Scars Market by Country
6.2 Asia Pacific Hypertrophic & Keloid Scars Market by Country
6.3 Asia Pacific Contracture Scars Market by Country
6.4 Asia Pacific Stretch Marks Market by Country
Chapter 7. Asia Pacific Scar Treatment Market by Country
7.1 China Scar Treatment Market
7.1.1 China Scar Treatment Market by End-use
7.1.2 China Scar Treatment Market by Product
7.1.2.1 China Scar Treatment Market by Topical Products Type
7.1.3 China Scar Treatment Market by Scar Type
7.2 Japan Scar Treatment Market
7.2.1 Japan Scar Treatment Market by End-use
7.2.2 Japan Scar Treatment Market by Product
7.2.2.1 Japan Scar Treatment Market by Topical Products Type
7.2.3 Japan Scar Treatment Market by Scar Type
7.3 India Scar Treatment Market
7.3.1 India Scar Treatment Market by End-use
7.3.2 India Scar Treatment Market by Product
7.3.2.1 India Scar Treatment Market by Topical Products Type
7.3.3 India Scar Treatment Market by Scar Type
7.4 South Korea Scar Treatment Market
7.4.1 South Korea Scar Treatment Market by End-use
7.4.2 South Korea Scar Treatment Market by Product
7.4.2.1 South Korea Scar Treatment Market by Topical Products Type
7.4.3 South Korea Scar Treatment Market by Scar Type
7.5 Singapore Scar Treatment Market
7.5.1 Singapore Scar Treatment Market by End-use
7.5.2 Singapore Scar Treatment Market by Product
7.5.2.1 Singapore Scar Treatment Market by Topical Products Type
7.5.3 Singapore Scar Treatment Market by Scar Type
7.6 Malaysia Scar Treatment Market
7.6.1 Malaysia Scar Treatment Market by End-use
7.6.2 Malaysia Scar Treatment Market by Product
7.6.2.1 Malaysia Scar Treatment Market by Topical Products Type
7.6.3 Malaysia Scar Treatment Market by Scar Type
7.7 Rest of Asia Pacific Scar Treatment Market
7.7.1 Rest of Asia Pacific Scar Treatment Market by End-use
7.7.2 Rest of Asia Pacific Scar Treatment Market by Product
7.7.2.1 Rest of Asia Pacific Scar Treatment Market by Topical Products Type
7.7.3 Rest of Asia Pacific Scar Treatment Market by Scar Type
Chapter 8. Company Profiles
8.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Product Line and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.1.5.2 Acquisitions and Mergers:
8.2 Perrigo Company PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Bausch Health Companies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 Sientra, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Molnlycke Health Care AB (Investor AB)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.6 Smith & Nephew PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional and Segmental Analysis
8.6.4 Research & Development Expense
8.7 Cynosure, LLC
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.7.2.2 Product Launches and Product Expansions:
8.8 Suneva Medical, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 Lumenis Be Ltd.
8.9.1 Company Overview
8.10. Merz Pharma GmbH & Co. KGaA
8.10.1 Company Overview
Companies Mentioned
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Cynosure, LLC
- Molnlycke Health Care AB (Investor AB)
- Suneva Medical, Inc.
- Perrigo Company PLC
- Sientra, Inc.
- Bausch Health Companies, Inc.
- Alma Lasers (Sisram Medical Ltd.)
Methodology
LOADING...
